Correlation Between Shattuck Labs and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Shattuck Labs and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shattuck Labs and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shattuck Labs and Citius Oncology,, you can compare the effects of market volatilities on Shattuck Labs and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shattuck Labs with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shattuck Labs and Citius Oncology,.
Diversification Opportunities for Shattuck Labs and Citius Oncology,
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Shattuck and Citius is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Shattuck Labs and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Shattuck Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shattuck Labs are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Shattuck Labs i.e., Shattuck Labs and Citius Oncology, go up and down completely randomly.
Pair Corralation between Shattuck Labs and Citius Oncology,
Given the investment horizon of 90 days Shattuck Labs is expected to generate 0.65 times more return on investment than Citius Oncology,. However, Shattuck Labs is 1.54 times less risky than Citius Oncology,. It trades about 0.02 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.15 per unit of risk. If you would invest 241.00 in Shattuck Labs on September 14, 2024 and sell it today you would lose (121.00) from holding Shattuck Labs or give up 50.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 17.81% |
| Values | Daily Returns |
Shattuck Labs vs. Citius Oncology,
Performance |
| Timeline |
| Shattuck Labs |
| Citius Oncology, |
Shattuck Labs and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Shattuck Labs and Citius Oncology,
The main advantage of trading using opposite Shattuck Labs and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shattuck Labs position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Shattuck Labs vs. Puma Biotechnology | Shattuck Labs vs. Iovance Biotherapeutics | Shattuck Labs vs. Day One Biopharmaceuticals | Shattuck Labs vs. Inozyme Pharma |
| Citius Oncology, vs. Molecular Partners AG | Citius Oncology, vs. MediciNova | Citius Oncology, vs. Anebulo Pharmaceuticals | Citius Oncology, vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |